Solventum Co. (NYSE:SOLV) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Solventum Co. (NYSE:SOLV - Free Report) by 5.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,106,194 shares of the company's stock after acquiring an additional 52,423 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.64% of Solventum worth $73,075,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in SOLV. Clarity Asset Management Inc. acquired a new stake in shares of Solventum during the 4th quarter worth approximately $25,000. Stonebridge Financial Group LLC bought a new stake in Solventum in the 4th quarter worth about $26,000. Raiffeisen Bank International AG purchased a new position in Solventum in the fourth quarter worth $29,000. Crews Bank & Trust purchased a new stake in Solventum during the fourth quarter worth about $32,000. Finally, Colonial Trust Co SC grew its position in shares of Solventum by 240.7% during the 4th quarter. Colonial Trust Co SC now owns 511 shares of the company's stock valued at $34,000 after acquiring an additional 361 shares during the period.

Solventum Price Performance

Shares of Solventum stock traded down $0.39 during trading on Friday, reaching $72.22. 375,498 shares of the stock traded hands, compared to its average volume of 1,238,407. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. The company has a market capitalization of $12.50 billion and a price-to-earnings ratio of 33.55. Solventum Co. has a 52-week low of $47.16 and a 52-week high of $85.92. The business has a fifty day simple moving average of $69.48 and a two-hundred day simple moving average of $71.27.

Solventum (NYSE:SOLV - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $1.34 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.19 by $0.15. The firm had revenue of $2.07 billion during the quarter, compared to the consensus estimate of $2.02 billion. During the same period in the previous year, the firm earned $2.08 EPS. The business's revenue was up 2.7% compared to the same quarter last year. Sell-side analysts expect that Solventum Co. will post 6.58 EPS for the current year.

Wall Street Analyst Weigh In

SOLV has been the subject of several recent research reports. Wells Fargo & Company lifted their price objective on Solventum from $73.00 to $75.00 and gave the stock an "equal weight" rating in a report on Friday, February 28th. Piper Sandler upgraded shares of Solventum from a "neutral" rating to an "overweight" rating and boosted their target price for the company from $78.00 to $87.00 in a research note on Monday, May 19th. Bank of America lifted their price objective on Solventum from $80.00 to $85.00 and gave the company a "neutral" rating in a research report on Wednesday, February 26th. Mizuho increased their price target on Solventum from $70.00 to $82.00 and gave the stock a "neutral" rating in a research note on Monday, March 3rd. Finally, The Goldman Sachs Group boosted their price objective on Solventum from $63.00 to $71.00 and gave the company a "sell" rating in a research report on Monday, March 3rd. One research analyst has rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $80.29.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.